Nigerian kid's new lease of life after bone marrow transplant

Bs_logoImage
Press Trust of India New Delhi
Last Updated : Nov 25 2014 | 10:20 PM IST
A four-year-old Nigerian boy, who suffered from life-threatening sickle cell disease, has got a new lease of life after undergoing a rare bone marrow transplant here.
Ekundayo was diagnosed with the disease when he was just one year old and started having severe joint pain requiring frequent hospitalisation. The only option was bone marrow transplant.
This disease is an inherited disorder of haemoglobin and distorted (sickled) red blood cells are produced. When the number of red blood cells decreases from rupture (hemolysis), it results in anemia.
The irregular sickled cells can also block blood vessels causing tissue and organ damage and pain, doctors say.
Ekundayo's parents then brought him to Dr Gaurav Kharya at the BLK Super Speciality hospital.
They opted for a haplo-identical transplant, a new transplant strategy, and the boy's father agreed to become a donor.
"Nathan was brought to the hospital in a serious condition with acute chest syndrome and complaints of severe joint pain. His sickle cell haemoglobin had increased to 88 per cent which worsened the condition further. Nathan was also prone to have life threatening stroke if we delayed treatment," said Kharya, senior consultant at BLK's Centre for Bone Marrow Transplant.
He explained that blood transfusion was given initially for two months to bring down his sickle level as direct transplant would have increased chance of rejection.
Post transplant he showed good recovery and new marrow started working on day 12. His chimerism (DNA testing) done on day 14 showed 99.45 per cent bone marrow precursor cells from his father, Kharya said.
He was successfully discharged on the 20th day, having sickle haemoglobin level decreased with 10 per cent post transplant.
"So far haplo-identical transplant in disease like SCD was very limited due to poor success rate. With improved strategies, we can get good results with relatively less complications," said Dr Dharma Choudhary, director of the centre.

You’ve reached your limit of 5 free articles this month.
Subscribe now for unlimited access.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories

  • Over 30 subscriber-only stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 25 2014 | 10:20 PM IST